Patent assignee · US · COMPANY

AVIDITY BIOSCIENCES, INC.

🏢 View company profile →
47Patents
47Active
47Granted
56Portfolio score

Filing activity: Mar 31, 2017 → Jul 15, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US10550188B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 69 Active
US10881743B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 45 Active
US11179472B2 Nucleic acid-polypeptide compositions and methods of inducing exon skipping Chemistry; Metallurgy 28 Active
US10994020B2 Nucleic acid-polypeptide compositions and methods of inducing exon skipping Chemistry; Metallurgy 25 Active
US11311627B1 Nucleic acid-polypeptide compositions and methods of inducing exon skipping Chemistry; Metallurgy 21 Active
US11400163B2 Nucleic acid-polypeptide compositions and methods of inducing exon skipping Chemistry; Metallurgy 19 Active
US10487149B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 17 Active
US10787519B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 17 Active
US11110180B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 16 Active
US10913800B2 Anti-transferrin receptor antibodies and uses thereof Chemistry; Metallurgy 13 Active
US12064483B2 Nucleic acid-polypeptide compositions and methods of inducing exon skipping Chemistry; Metallurgy 13 Active
US11028179B2 Anti-transferrin receptor antibodies and uses thereof Chemistry; Metallurgy 12 Active
US11555190B2 Compositions and methods of treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 10 Active
US11525137B2 Compositions and methods of treating Facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 9 Active
US11253607B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 7 Active
US11246941B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 7 Active
US10800848B2 Nucleic acid-polypeptide compositions and uses thereof Chemistry; Metallurgy 6 Active
US11576980B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 5 Active
US11446387B2 Compositions and methods of treating muscle dystrophy Chemistry; Metallurgy 4 Active
US11912779B2 Compositions and methods of treating facioscapulohumeral muscular dystrophy Chemistry; Metallurgy 4 Active
US11554176B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 2 Active
US12006499B2 Una amidites and uses thereof Chemistry; Metallurgy 2 Active
US11834510B2 Anti-transferrin receptor antibodies and uses thereof Chemistry; Metallurgy 2 Active
US11497814B2 Compositions and methods of treating muscle atrophy and myotonic dystrophy Chemistry; Metallurgy 2 Active
US12071621B2 Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.